Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 7,965 shares at $138.91 ($1.1M) on 2016-02-29, disclosed to the SEC on 2016-03-01.
Open-market sale of $1.1M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.91 | 3,970 | $551K | 49.8% |
| 2 | $138.91 | 3,970 | $551K | 49.8% |
| 3 | $140.58 | 25 | $4K | 0.3% |
| Total | $138.92 avg | 7,965 | $1.1M | 100% |
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |